The present invention is concerned with novel pyridazinone derivatives of formula (I)
wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
[EN] HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDAZONE À SUBSTITUTION HÉTÉROARYLE
申请人:HOFFMANN LA ROCHE
公开号:WO2010094762A1
公开(公告)日:2010-08-26
The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.
HETEROARYL SUBSTITUTED PYRIDAZINONE DERIVATIVES
申请人:Alberati Daniela
公开号:US20100216793A1
公开(公告)日:2010-08-26
The present invention is concerned with novel pyridazinone derivatives of formula (I)
wherein R
1
, R
2
, R
3
and R
4
are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.